Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Pretty Quiet / Gov Clinical Trials
View:
Post by FarmerBetty on May 16, 2023 11:30am

Pretty Quiet / Gov Clinical Trials

Tried to find Promis listed under US gov clinical trials where the alzheimers trials are listed as active, recruiting, etc. Might mean nothing but would of thought with all the delays that if they were serious about going into the clinic the company would have the foot on the pedal.
Comment by G1945V on May 17, 2023 7:24am
Before PMN initiates Phase 1a they need the funding in place. "Cash and cash equivalents were $3.3 million as of March 31, 2023," G1945V